
TC BioPharm Teams up with Bluebird Bio to Develop Next Generation CAR T cells
Scottish biotech TC BioPharm enters into a collaboration and license agreement with bluebird bio (NASDAQ:BLUE) aimed at advancing the former’s CAR-engineered gamma delta T...